Forced expression of RNF36 induces cell apoptosis

Experimental Cell Research

Volumn 287, Issue 2, 2003, Pages 301-313

  Shyu, Huey Wen ^a,b   Hsu, Shih Hsien ^b   Hsieh Li, Hsiu Mei ^c   Li, Hung ^a,b,d  

^a NATIONAL DEFENSE UNIVERSITY   (Taiwan)

^b INSTITUTE OF MOLECULAR BIOLOGY   (Taiwan)

^c TAIPEI MEDICAL UNIVERSITY   (Taiwan)

^d NATIONAL YANG MING UNIVERSITY   (Taiwan)

Author keywords

Apoptosis; Caspases; PML; RING zinc finger protein

Indexed keywords

4 (4 FLUOROPHENYL) 2 (4 METHYLSULFINYLPHENYL) 5 (4 PYRIDYL)IMIDAZOLE; CASPASE 2; DNA FRAGMENT; ONCOPROTEIN; PROMYELOCYTIC LEUKEMIA PROTEIN; PROTEIN; PROTEIN BAX; PROTEIN INHIBITOR; RING FINGER PROTEIN 36; SYNAPTOPHYSIN; UNCLASSIFIED DRUG; ZINC FINGER PROTEIN; BAX PROTEIN, HUMAN; CASPASE; DNA BINDING PROTEIN; ENZYME INHIBITOR; GREEN FLUORESCENT PROTEIN; HYBRID PROTEIN; IMIDAZOLE DERIVATIVE; MITOGEN ACTIVATED PROTEIN KINASE; MITOGEN ACTIVATED PROTEIN KINASE P38; PHOTOPROTEIN; PROTEIN BCL 2; PYRIDINE DERIVATIVE; RNF36 PROTEIN, MOUSE; TUMOR PROTEIN;

ANIMAL CELL; APOPTOSIS; ARTICLE; CELL NUCLEUS; CELL STRAIN COS7; CELLULAR DISTRIBUTION; CONTROLLED STUDY; DNA DAMAGE; EMBRYO; FIBROBLAST; FLOW CYTOMETRY; GENE OVEREXPRESSION; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; IMMUNOPRECIPITATION; KIDNEY CELL; NICK END LABELING; NONHUMAN; NUCLEAR LOCALIZATION SIGNAL; NUCLEOCYTOPLASMIC TRANSPORT; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROMYELOCYTIC LEUKEMIA; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN INDUCTION; PROTEIN LOCALIZATION; PROTEIN PHOSPHORYLATION; PROTEIN PROTEIN INTERACTION; SOMATIC CELL; STAINING; ANIMAL; CELL INCLUSION; CELL LINE; CELL STRAIN COS1; CERCOPITHECUS; CYTOPLASM; DRUG EFFECT; GENE EXPRESSION; GENETICS; METABOLISM; PHOSPHORYLATION; PHYSIOLOGY;

ALIAS;

ANIMALS; APOPTOSIS; BCL-2-ASSOCIATED X PROTEIN; CASPASES; CELL LINE; CELL NUCLEUS; CERCOPITHECUS AETHIOPS; COS CELLS; CYTOPLASM; DNA-BINDING PROTEINS; ENZYME INHIBITORS; GENE EXPRESSION; GREEN FLUORESCENT PROTEINS; HUMANS; IMIDAZOLES; INCLUSION BODIES; LEUKEMIA, PROMYELOCYTIC, ACUTE; LUMINESCENT PROTEINS; MITOGEN-ACTIVATED PROTEIN KINASES; NEOPLASM PROTEINS; P38 MITOGEN-ACTIVATED PROTEIN KINASES; PHOSPHORYLATION; PROTO-ONCOGENE PROTEINS; PROTO-ONCOGENE PROTEINS C-BCL-2; PYRIDINES; RECOMBINANT FUSION PROTEINS; ZINC FINGERS;

EID: 0041703139     PISSN: 00144827     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0014-4827(03)00110-1     Document Type: Article

References (58)

1. Shyu H.W., Hsu S.H., Hsieh-Li H.M., Li H. A novel member of the RBCC family, Trif, expressed specifically in the spermatids of mouse testis. Mech. Dev. 108:2001;213-216.
2. Saurin A.J., Borden K.L., Boddy M.N., Freemont P.S. Does this have a familiar RING? Trends Biochem. Sci. 21:1996;208-214.
3. Cao T., Borden K.L., Freemont P.S., Etkin L.D. Involvement of the rfp tripartite motif in protein-protein interactions and subcellular distribution. J. Cell Sci. 110:(Pt 14):1997;1563-1571.
4. Borden K.L. RING domains master builders of molecular scaffolds? J. Mol. Biol. 295:2000;1103-1112.
5. Freemont P.S. RING for destruction? Curr. Biol. 10:2000;R84-R87.
6. Borden K.L., Freemont P.S. The RING finger domain a recent example of a sequence-structure family. Curr. Opin. Struct. Biol. 6:1996;395-401.
7. Le Douarin B., Nielsen A.L., Garnier J.M., Ichinose H., Jeanmougin F., Losson R., Chambon P. A possible involvement of TIF1 alpha and TIF1 beta in the epigenetic control of transcription by nuclear receptors. EMBO J. 15:1996;6701-6715.
8. Mu Z.M., Chin K.V., Liu J.H., Lozano G., Chang K.S. PML, a growth suppressor disrupted in acute promyelocytic leukemia. Mol. Cell. Biol. 14:1994;6858-6867.
9. Liu J.H., Mu Z.M., Chang K.S. PML suppresses oncogenic transformation of NIH/3T3 cells by activated neu. J. Exp. Med. 181:1995;1965-1973.
10. Le X.F., Vallian S., Mu Z.M., Hung M.C., Chang K.S. Recombinant PML adenovirus suppresses growth and tumorigenicity of human breast cancer cells by inducing G1 cell cycle arrest and apoptosis. Oncogene. 16:1998;1839-1849.
11. Guo A., Salomoni P., Luo J., Shih A., Zhong S., Gu W., Paolo Pandolfi P. The function of PML in p53-dependent apoptosis. Nat. Cell Biol. 2:2000;730-736.
12. Doucas V., Tini M., Egan D.A., Evans R.M. Modulation of CREB binding protein function by the promyelocytic (PML) oncoprotein suggests a role for nuclear bodies in hormone signaling. Proc. Natl. Acad. Sci. USA. 96:1999;2627-2632.
13. Wu W.S., Vallian S., Seto E., Yang W.M., Edmondson D., Roth S., Chang K.S. The growth suppressor PML represses transcription by functionally and physically interacting with histone deacetylases. Mol. Cell. Biol. 21:2001;2259-2268.
14. LaMorte V.J., Dyck J.A., Ochs R.L., Evans R.M. Localization of nascent RNA and CREB binding protein with the PML-containing nuclear body. Proc. Natl. Acad. Sci. USA. 95:1998;4991-4996.
15. Doucas V., Evans R.M. Human T-cell leukemia retrovirus-Tax protein is a repressor of nuclear receptor signaling. Proc. Natl. Acad. Sci. USA. 96:1999;2633-2638.
16. Zhong S., Delva L., Rachez C., Cenciarelli C., Gandini D., Zhang H., Kalantry S., Freedman L.P., Pandolfi P.P. A RA-dependent, tumour-growth suppressive transcription complex is the target of the PML-RARalpha and T18 oncoproteins. Nat. Genet. 23:1999;287-295.
17. Boisvert F.M., Kruhlak M.J., Box A.K., Hendzel M.J., Bazett-Jones D.P. The transcription coactivator CBP is a dynamic component of the promyelocytic leukemia nuclear body. J. Cell Biol. 152:2001;1099-1106.
18. Boisvert F.M., Hendzel M.J., Bazett-Jones D.P. Promyelocytic leukemia (PML) nuclear bodies are protein structures that do not accumulate RNA. J. Cell Biol. 148:2000;283-292.
19. Vallian S., Gaken J.A., Gingold E.B., Kouzarides T., Chang K.S., Farzaneh F. Modulation of Fos-mediated AP-1 transcription by the promyelocytic leukemia protein. Oncogene. 16:1998;2843-2853.
20. Ferbeyre G., de Stanchina E., Querido E., Baptiste N., Prives C., Lowe S.W. PML is induced by oncogenic ras and promotes premature senescence. Genes Dev. 14:2000;2015-2027.
21. Pearson M., Carbone R., Sebastiani C., Cioce M., Fagioli M., Saito S., Higashimoto Y., Appella E., Minucci S., Pandolfi P.P., Pelicci P.G. PML regulates p53 acetylation and premature senescence induced by oncogenic Ras. Nature. 406:2000;207-210.
22. Tsuzuki S., Towatari M., Saito H., Enver T. Potentiation of GATA-2 activity through interactions with the promyelocytic leukemia protein (PML) and the t(15;17)-generated PML-retinoic acid receptor alpha oncoprotein. Mol. Cell. Biol. 20:2000;6276-6286.
23. Vallian S., Gaken J.A., Trayner I.D., Gingold E.B., Kouzarides T., Chang K.S., Farzaneh F. Transcriptional repression by the promyelocytic leukemia protein, PML. Exp. Cell Res. 237:1997;371-382.
24. Vallian S., Chin K.V., Chang K.S. The promyelocytic leukemia protein interacts with Sp1 and inhibits its transactivation of the epidermal growth factor receptor promoter. Mol. Cell. Biol. 18:1998;7147-7156.
25. Li H., Leo C., Zhu J., Wu X., O'Neil J., Park E.J., Chen J.D. Sequestration and inhibition of Daxx-mediated transcriptional repression by PML. Mol. Cell. Biol. 20:2000;1784-1796.
26. Khan M.M., Nomura T., Kim H., Kaul S.C., Wadhwa R., Shinagawa T., Ichikawa-Iwata E., Zhong S., Pandolfi P.P., Ishii S. Role of PML and PML-RARalpha in Mad-mediated transcriptional repression. Mol. Cell. 7:2001;1233-1243.
27. Wyllie A.H., Kerr J.F., Currie A.R. Cell death the significance of apoptosis. Int. Rev. Cytol. 68:1980;251-306.
28. Raff M.C. Social controls on cell survival and cell death. Nature. 356:1992;397-400.
29. Vaux D.L., Cory S., Adams J.M. Bcl-2 gene promotes haemopoietic cell survival and cooperates with c-myc to immortalize pre-B cells. Nature. 335:1988;440-442.
30. Yin Y., DeWolf W.C., Morgentaler A. Experimental cryptorchidism induces testicular germ cell apoptosis by p53-dependent and -independent pathways in mice. Biol. Reprod. 58:1998;492-496.
31. Dang J., Kuo M.L., Eischen C.M., Stepanova L., Sherr C.J., Roussel M.F. The RING domain of Mdm2 can inhibit cell proliferation. Cancer Res. 62:2002;1222-1230.
32. Yang E., Zha J., Jockel J., Boise L.H., Thompson C.B., Korsmeyer S.J. Bad, a heterodimeric partner for Bcl-XL and Bcl-2, displaces Bax and promotes cell death. Cell. 80:1995;285-291.
33. Hale A.J., Smith C.A., Sutherland L.C., Stoneman V.E., Longthorne V., Culhane A.C., Williams G.T. Apoptosis molecular regulation of cell death. Eur. J. Biochem. 237:1996;884.
34. Oltvai Z.N., Milliman C.L., Korsmeyer S.J. Bcl-2 heterodimerizes in vivo with a conserved homolog, Bax, that accelerates programmed cell death. Cell. 74:1993;609-619.
35. Russell L.D., Weiss T., Goh J.C., Curl J.L. The effect of submandibular gland removal on testicular and epididymal parameters. Tissue Cell. 22:1990;263-268.
36. Sedlak T.W., Oltvai Z.N., Yang E., Wang K., Boise L.H., Thompson C.B., Korsmeyer S.J. Multiple Bcl-2 family members demonstrate selective dimerizations with Bax. Proc. Natl. Acad. Sci. USA. 92:1995;7834-7838.
37. Shi Y.P., Mohapatra G., Miller J., Hanahan D., Lander E., Gold P., Pinkel D., Gray J. FISH probes for mouse chromosome identification. Genomics. 45:1997;42-47.
38. Gossen M., Bujard H. Efficacy of tetracycline-controlled gene expression is influenced by cell type commentary. Biotechniques. 19:1995;213-216 discussion 216-217.
39. Geum D., Son G.H., Kim K. Phosphorylation-dependent cellular localization and thermoprotective role of heat shock protein 25 in hippocampal progenitor cells. J. Biol. Chem. 277:2002;19913-19921.
40. Eom Y.W., Cho S.H., Hwang J.S., Yoon S.B., Na D.S., Kang I.J., Kang S.S., Song W.K., Kim J.H. Rac and p38 kinase mediate 5-lipoxygenase translocation and cell death. Biochem. Biophys. Res. Commun. 284:2001;126-132.
41. Zhong S., Salomoni P., Pandolfi P.P. The transcriptional role of PML and the nuclear body. Nat. Cell Biol. 2:2000;E85-E90.
42. Quignon F., De Bels F., Koken M., Feunteun J.C., Ameisen J., de The H. PML induces a novel caspase-independent death process. Nat. Genet. 20:1998;259-265.
43. Wang Z.G., Ruggero D., Ronchetti S., Zhong S., Gaboli M., Rivi R., Pandolfi P.P. PML is essential for multiple apoptotic pathways. Nat. Genet. 20:1998;266-272.
44. Mu Z.M., Le X.F., Vallian S., Glassman A.B., Chang K.S. Stable overexpression of PML alters regulation of cell cycle progression in HeLa cells. Carcinogenesis. 18:1997;2063-2069.
45. Fogal V., Gostissa M., Sandy P., Zacchi P., Sternsdorf T., Jensen K., Pandolfi P.P., Will H., Schneider C., Del Sal G. Regulation of p53 activity in nuclear bodies by a specific PML isoform. EMBO J. 19:2000;6185-6195.
46. Butt A.J., Firth S.M., King M.A., Baxter R.C. Insulin-like growth factor-binding protein-3 modulates expression of Bax and Bcl-2 and potentiates p53-independent radiation-induced apoptosis in human breast cancer cells. J. Biol. Chem. 275:2000;39174-39181.
47. Miyashita T., Reed J.C. Tumor suppressor p53 is a direct transcriptional activator of the human bax gene. Cell. 80:1995;293-299.
48. Strasser A., Harris A.W., Jacks T., Cory S. DNA damage can induce apoptosis in proliferating lymphoid cells via p53-independent mechanisms inhibitable by Bcl-2. Cell. 79:1994;329-339.
49. Ishida M., Gomyo Y., Ohfuji S., Ikeda M., Kawasaki H., Ito H. Evidence that expression of a mutated p53 gene attenuates apoptotic cell deat in human gastric intestinal-type carcinomas in vivo. Jpn. J. Cancer Res. 88:1997;468-475.
50. Bredesen D.E. Apoptosis overview and signal transduction pathways. J Neurotrauma. 17:2000;801-810.
51. Duan H., Dixit V.M. RAIDD is a new 'death' adaptor molecule. Nature. 385:1997;86-89.
52. Grimm S., Stanger B.Z., Leder P. RIP and FADD two "death domain" -containing proteins can induce apoptosis by convergent, but dissociable, pathways. Proc. Natl. Acad. Sci. USA. 93:1996;10923-10937.
53. Hsu H., Huang J., Shu H.B., Baichwal V., Goeddel D.V. TNF-dependent recruitment of the protein kinase RIP to the TNF receptor-1 signaling complex. Immunity. 4:1996;387-396.
54. Allan D.J., Harmon B.V., Roberts S.A. Spermatogonial apoptosis has three morphologically recognizable phases and shows no circadian rhythm during normal spermatogenesis in the rat. Cell Proliferation. 25:1992;241-250.
55. Sharpe R.M., Kerr J.B., McKinnell C., Millar M. Temporal relationship between androgen-dependent changes in the volume of seminiferous tubule fluid, lumen size and seminiferous tubule protein secretion in rats. J. Reprod. Fertil. 101:1994;193-198.
56. Kierszenbaum A.L. Apoptosis during spermatogenesis the thrill of being alive. Mol. Reprod. Dev. 58:2001;1-3.
57. Yan W., Suominen J., Samson M., Jegou B., Toppari J. Involvement of Bcl-2 family proteins in germ cell apoptosis during testicular development in the rat and pro-survival effect of stem cell factor on germ cells in vitro. Mol. Cell. Endocrinol. 165:2000;115-129.
58. Oldereid N.B., Angelis P.D., Wiger R., Clausen O.P. Expression of Bcl-2 family proteins and spontaneous apoptosis in normal human testis. Mol. Hum. Reprod. 7:2001;403-408.